efficacy of epcoritamab and glofitamab in diffuse large b-cell lymphoma - blood cancers onctalk 2023
Published 6 months ago • 128 plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
3:02
efficacy of epcoritamab and glofitamab in diffuse large b-cell lymphoma
-
6:06
bispecific antibody treatment in non-hodgkin lymphoma: epcoritamab - blood cancers onctalk 2023
-
2:52
bispecific antibody treatment in non-hodgkin lymphoma: glofitamab - blood cancers onctalk 2023
-
1:19
q&a: do bispecifics cure diffuse large b-cell lymphoma? - blood cancer onctalk 2023
-
3:52
glofitamab & pirtobrutinib for relapsed/refractory mantle cell lymphoma -blood cancers video library
-
1:56
types of bispecific antibodies - blood cancer onctalk 2023
-
1:37
pros and cons of bispecific antibodies - blood cancer onctalk 2023
-
3:53
the future of bispecific antibodies - blood cancer onctalk 2023
-
3:56
bispecific antibodies in myeloma: approvals and clinical trials - blood cancer onctalk 2023
-
3:34
transplants in myeloma and lymphoma: effects on survival - blood cancer onctalk 2023
-
4:44
mosunetuzumab for follicular lymphoma - blood cancer onctalk 2023
-
1:05
q&a: does bispecific treatment for lymphoma affect fertility? - blood cancer onctalk 2023
-
4:53
immunotherapy treatments b-cell non-hodgkin's: bispecific antibodies - blood cancer video library
-
2:53
management of bispecific antibodies side effects - blood cancer onctalk 2023
-
3:36
q&a: financial or location limitations to bispecific antibody treatments? -blood cancer onctalk 2023
-
3:12
what are the pros and cons of car t-cell therapy vs. bispecific antibodies? - blood cancer onctalk
-
2:39
q&a: bispecific treatment in lymphoma: key doctor discussions - blood cancer onctalk 2023